
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Therapeutic efficacy of the resorcylic acid lactone LL&#8208;Z1640&#8208;2 for adult T&#8208;cell leukaemia/lymphoma - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC5000033920E001DE4.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="ejhaem" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10435715/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435715/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="EJHaem" /><meta name="citation_title" content="Therapeutic efficacy of the resorcylic acid lactone LL&#x02010;Z1640&#x02010;2 for adult T&#x02010;cell leukaemia/lymphoma" /><meta name="citation_author" content="Masahiro Oura" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Takeshi Harada" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Asuka Oda" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Jumpei Teramachi" /><meta name="citation_author_institution" content="Department of Oral Function and Anatomy, Graduate School of Medicine Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama Japan" /><meta name="citation_author" content="Atsushi Nakayama" /><meta name="citation_author_institution" content="Graduate School of Science, Osaka Metropolitan University, Osaka Japan" /><meta name="citation_author" content="Ryohei Sumitani" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Yusuke Inoue" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Yusaku Maeda" /><meta name="citation_author_institution" content="Department of Hematology, Tokushima University Hospital, Tokushima Japan" /><meta name="citation_author" content="Kimiko Sogabe" /><meta name="citation_author_institution" content="Department of Hematology, Tokushima University Hospital, Tokushima Japan" /><meta name="citation_author" content="Tomoko Maruhashi" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Mamiko Takahashi" /><meta name="citation_author_institution" content="Department of Hematology, Tokushima University Hospital, Tokushima Japan" /><meta name="citation_author" content="Shiro Fujii" /><meta name="citation_author_institution" content="Department of Hematology, Tokushima University Hospital, Tokushima Japan" /><meta name="citation_author" content="Shingen Nakamura" /><meta name="citation_author_institution" content="Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Hirokazu Miki" /><meta name="citation_author_institution" content="Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima Japan" /><meta name="citation_author" content="Masafumi Nakamura" /><meta name="citation_author_institution" content="Department of Internal Medicine, Tokushima Prefecture Naruto Hospital, Tokushima Japan" /><meta name="citation_author" content="Tomoyo Hara" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Hiroki Yamagami" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Kiyoe Kurahashi" /><meta name="citation_author_institution" content="Department of Community Medicine for Respirology, Hematology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Itsuro Endo" /><meta name="citation_author_institution" content="Department of Bioregulatory Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_author" content="Hiroo Hasegawa" /><meta name="citation_author_institution" content="Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki Japan" /><meta name="citation_author" content="Hiroshi Fujiwara" /><meta name="citation_author_institution" content="Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Mie Japan" /><meta name="citation_author" content="Masahiro Abe" /><meta name="citation_author_institution" content="Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima Japan" /><meta name="citation_publication_date" content="2023/08" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="4" /><meta name="citation_firstpage" content="667" /><meta name="citation_doi" content="10.1002/jha2.758" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10435715/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10435715/" /><meta name="citation_pmid" content="37601887" /><meta name="DC.Title" content="Therapeutic efficacy of the resorcylic acid lactone LL&#x02010;Z1640&#x02010;2 for adult T&#x02010;cell leukaemia/lymphoma" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Wiley" /><meta name="DC.Contributor" content="Masahiro Oura" /><meta name="DC.Contributor" content="Takeshi Harada" /><meta name="DC.Contributor" content="Asuka Oda" /><meta name="DC.Contributor" content="Jumpei Teramachi" /><meta name="DC.Contributor" content="Atsushi Nakayama" /><meta name="DC.Contributor" content="Ryohei Sumitani" /><meta name="DC.Contributor" content="Yusuke Inoue" /><meta name="DC.Contributor" content="Yusaku Maeda" /><meta name="DC.Contributor" content="Kimiko Sogabe" /><meta name="DC.Contributor" content="Tomoko Maruhashi" /><meta name="DC.Contributor" content="Mamiko Takahashi" /><meta name="DC.Contributor" content="Shiro Fujii" /><meta name="DC.Contributor" content="Shingen Nakamura" /><meta name="DC.Contributor" content="Hirokazu Miki" /><meta name="DC.Contributor" content="Masafumi Nakamura" /><meta name="DC.Contributor" content="Tomoyo Hara" /><meta name="DC.Contributor" content="Hiroki Yamagami" /><meta name="DC.Contributor" content="Kiyoe Kurahashi" /><meta name="DC.Contributor" content="Itsuro Endo" /><meta name="DC.Contributor" content="Hiroo Hasegawa" /><meta name="DC.Contributor" content="Hiroshi Fujiwara" /><meta name="DC.Contributor" content="Masahiro Abe" /><meta name="DC.Date" content="2023 Aug" /><meta name="DC.Identifier" content="10.1002/jha2.758" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Therapeutic efficacy of the resorcylic acid lactone LL&#x02010;Z1640&#x02010;2 for adult T&#x02010;cell leukaemia/lymphoma" /><meta property="og:type" content="article" /><meta property="og:description" content="Adult T&#x02010;cell leukaemia/lymphoma (ATL) remains incurable. The NF&#x02010;&#x003ba;B and interferon regulatory factor 4 (IRF4) signalling pathways are among the critical survival pathways for the progression of ATL. TGF&#x02010;&#x003b2;&#x02010;activated ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435715/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10435715/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/4199/">EJHaem</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/443375/">v.4(3); 2023 Aug</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10435715
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10435715/pdf/JHA2-4-667.pdf" class="int-view">PDF (2.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10435715/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10435715/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10435715" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10435715%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="Ox0UX80RlFNysx2M2ugJvfu9FAMbg2MRVBMwLl2YA54Iei3xsmM6r66VU0BSBb6K">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10435715%2F&amp;text=Therapeutic%20efficacy%20of%20the%20resorcylic%20acid%20lactone%20LL%02010Z1640%020102%20for%20adult%20T%02010cell%20leukaemia%2Flymphoma%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10435715%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435715/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10435715/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37601887/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10435715/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37601887/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10435715/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10435715/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/4199/">EJHaem</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/443375/">v.4(3); 2023 Aug</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10435715
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-ejhaem.jpg" alt="Logo of ejhaem" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://onlinelibrary.wiley.com/journal/26886146" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">EJHaem.</span> 2023 Aug; 4(3): 667–678. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jul 27. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1002%2Fjha2.758" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1002/jha2.758</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10435715</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37601887">37601887</a></div></div></div><h1 class="content-title">Therapeutic efficacy of the resorcylic acid lactone LL&#x02010;Z1640&#x02010;2 for adult T&#x02010;cell leukaemia/lymphoma</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Oura%20M%5BAuthor%5D" id="jha2758-cr-0001" class="affpopup" co-rid="_co_idm140303011508192" co-class="co-affbox">Masahiro Oura</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Harada%20T%5BAuthor%5D" id="jha2758-cr-0002" class="affpopup" co-rid="_co_idm140303011492544" co-class="co-affbox">Takeshi Harada</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Oda%20A%5BAuthor%5D" id="jha2758-cr-0003" class="affpopup" co-rid="_co_idm140303011488576" co-class="co-affbox">Asuka Oda</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Teramachi%20J%5BAuthor%5D" id="jha2758-cr-0004" class="affpopup" co-rid="_co_idm140303011485968" co-class="co-affbox">Jumpei Teramachi</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nakayama%20A%5BAuthor%5D" id="jha2758-cr-0005" class="affpopup" co-rid="_co_idm140303011124320" co-class="co-affbox">Atsushi Nakayama</a>,<sup>
3
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sumitani%20R%5BAuthor%5D" id="jha2758-cr-0006" class="affpopup" co-rid="_co_idm140303011120976" co-class="co-affbox">Ryohei Sumitani</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Inoue%20Y%5BAuthor%5D" id="jha2758-cr-0007" class="affpopup" co-rid="_co_idm140303011118368" co-class="co-affbox">Yusuke Inoue</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Maeda%20Y%5BAuthor%5D" id="jha2758-cr-0008" class="affpopup" co-rid="_co_idm140303011115760" co-class="co-affbox">Yusaku Maeda</a>,<sup>
4
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sogabe%20K%5BAuthor%5D" id="jha2758-cr-0009" class="affpopup" co-rid="_co_idm140303011113152" co-class="co-affbox">Kimiko Sogabe</a>,<sup>
4
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Maruhashi%20T%5BAuthor%5D" id="jha2758-cr-0010" class="affpopup" co-rid="_co_idm140303011110544" co-class="co-affbox">Tomoko Maruhashi</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Takahashi%20M%5BAuthor%5D" id="jha2758-cr-0011" class="affpopup" co-rid="_co_idm140303011107936" co-class="co-affbox">Mamiko Takahashi</a>,<sup>
4
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fujii%20S%5BAuthor%5D" id="jha2758-cr-0012" class="affpopup" co-rid="_co_idm140303011105328" co-class="co-affbox">Shiro Fujii</a>,<sup>
4
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nakamura%20S%5BAuthor%5D" id="jha2758-cr-0013" class="affpopup" co-rid="_co_idm140303011101984" co-class="co-affbox">Shingen Nakamura</a>,<sup>
5
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Miki%20H%5BAuthor%5D" id="jha2758-cr-0014" class="affpopup" co-rid="_co_idm140303011098640" co-class="co-affbox">Hirokazu Miki</a>,<sup>
6
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nakamura%20M%5BAuthor%5D" id="jha2758-cr-0015" class="affpopup" co-rid="_co_idm140303011095296" co-class="co-affbox">Masafumi Nakamura</a>,<sup>
7
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hara%20T%5BAuthor%5D" id="jha2758-cr-0016" class="affpopup" co-rid="_co_idm140303011092688" co-class="co-affbox">Tomoyo Hara</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamagami%20H%5BAuthor%5D" id="jha2758-cr-0017" class="affpopup" co-rid="_co_idm140303011090080" co-class="co-affbox">Hiroki Yamagami</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kurahashi%20K%5BAuthor%5D" id="jha2758-cr-0018" class="affpopup" co-rid="_co_idm140303011087472" co-class="co-affbox">Kiyoe Kurahashi</a>,<sup>
8
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Endo%20I%5BAuthor%5D" id="jha2758-cr-0019" class="affpopup" co-rid="_co_idm140303011084864" co-class="co-affbox">Itsuro Endo</a>,<sup>
9
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hasegawa%20H%5BAuthor%5D" id="jha2758-cr-0020" class="affpopup" co-rid="_co_idm140303002853232" co-class="co-affbox">Hiroo Hasegawa</a>,<sup>
10
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fujiwara%20H%5BAuthor%5D" id="jha2758-cr-0021" class="affpopup" co-rid="_co_idm140303002850624" co-class="co-affbox">Hiroshi Fujiwara</a>,<sup>
11
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Abe%20M%5BAuthor%5D" id="jha2758-cr-0022" class="affpopup" co-rid="_co_idm140303002848016" co-class="co-affbox">Masahiro Abe</a><sup>
1
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140303011508192"><h3 class="no_margin">Masahiro Oura</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Oura%20M%5BAuthor%5D">Masahiro Oura</a></div></div><div id="_co_idm140303011492544"><h3 class="no_margin">Takeshi Harada</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Harada%20T%5BAuthor%5D">Takeshi Harada</a></div></div><div id="_co_idm140303011488576"><h3 class="no_margin">Asuka Oda</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Oda%20A%5BAuthor%5D">Asuka Oda</a></div></div><div id="_co_idm140303011485968"><h3 class="no_margin">Jumpei Teramachi</h3><p>
<sup>
2
</sup>
Department of Oral Function and Anatomy, 
Graduate School of Medicine Dentistry, 
and Pharmaceutical Sciences, 
Okayama University, 
Okayama
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Teramachi%20J%5BAuthor%5D">Jumpei Teramachi</a></div></div><div id="_co_idm140303011124320"><h3 class="no_margin">Atsushi Nakayama</h3><p>
<sup>
3
</sup>
Graduate School of Science, 
Osaka Metropolitan University, 
Osaka
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nakayama%20A%5BAuthor%5D">Atsushi Nakayama</a></div></div><div id="_co_idm140303011120976"><h3 class="no_margin">Ryohei Sumitani</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sumitani%20R%5BAuthor%5D">Ryohei Sumitani</a></div></div><div id="_co_idm140303011118368"><h3 class="no_margin">Yusuke Inoue</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Inoue%20Y%5BAuthor%5D">Yusuke Inoue</a></div></div><div id="_co_idm140303011115760"><h3 class="no_margin">Yusaku Maeda</h3><p>
<sup>
4
</sup>
Department of Hematology, 
Tokushima University Hospital, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Maeda%20Y%5BAuthor%5D">Yusaku Maeda</a></div></div><div id="_co_idm140303011113152"><h3 class="no_margin">Kimiko Sogabe</h3><p>
<sup>
4
</sup>
Department of Hematology, 
Tokushima University Hospital, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sogabe%20K%5BAuthor%5D">Kimiko Sogabe</a></div></div><div id="_co_idm140303011110544"><h3 class="no_margin">Tomoko Maruhashi</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Maruhashi%20T%5BAuthor%5D">Tomoko Maruhashi</a></div></div><div id="_co_idm140303011107936"><h3 class="no_margin">Mamiko Takahashi</h3><p>
<sup>
4
</sup>
Department of Hematology, 
Tokushima University Hospital, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Takahashi%20M%5BAuthor%5D">Mamiko Takahashi</a></div></div><div id="_co_idm140303011105328"><h3 class="no_margin">Shiro Fujii</h3><p>
<sup>
4
</sup>
Department of Hematology, 
Tokushima University Hospital, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fujii%20S%5BAuthor%5D">Shiro Fujii</a></div></div><div id="_co_idm140303011101984"><h3 class="no_margin">Shingen Nakamura</h3><p>
<sup>
5
</sup>
Department of Community Medicine and Medical Science, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nakamura%20S%5BAuthor%5D">Shingen Nakamura</a></div></div><div id="_co_idm140303011098640"><h3 class="no_margin">Hirokazu Miki</h3><p>
<sup>
6
</sup>
Division of Transfusion Medicine and Cell Therapy, 
Tokushima University Hospital, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Miki%20H%5BAuthor%5D">Hirokazu Miki</a></div></div><div id="_co_idm140303011095296"><h3 class="no_margin">Masafumi Nakamura</h3><p>
<sup>
7
</sup>
Department of Internal Medicine, 
Tokushima Prefecture Naruto Hospital, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nakamura%20M%5BAuthor%5D">Masafumi Nakamura</a></div></div><div id="_co_idm140303011092688"><h3 class="no_margin">Tomoyo Hara</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hara%20T%5BAuthor%5D">Tomoyo Hara</a></div></div><div id="_co_idm140303011090080"><h3 class="no_margin">Hiroki Yamagami</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamagami%20H%5BAuthor%5D">Hiroki Yamagami</a></div></div><div id="_co_idm140303011087472"><h3 class="no_margin">Kiyoe Kurahashi</h3><p>
<sup>
8
</sup>
Department of Community Medicine for Respirology, 
Hematology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kurahashi%20K%5BAuthor%5D">Kiyoe Kurahashi</a></div></div><div id="_co_idm140303011084864"><h3 class="no_margin">Itsuro Endo</h3><p>
<sup>
9
</sup>
Department of Bioregulatory Sciences, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Endo%20I%5BAuthor%5D">Itsuro Endo</a></div></div><div id="_co_idm140303002853232"><h3 class="no_margin">Hiroo Hasegawa</h3><p>
<sup>
10
</sup>
Department of Laboratory Medicine, 
Nagasaki University Hospital, 
Nagasaki
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hasegawa%20H%5BAuthor%5D">Hiroo Hasegawa</a></div></div><div id="_co_idm140303002850624"><h3 class="no_margin">Hiroshi Fujiwara</h3><p>
<sup>
11
</sup>
Department of Personalized Cancer Immunotherapy, 
Mie University Graduate School of Medicine, 
Mie
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fujiwara%20H%5BAuthor%5D">Hiroshi Fujiwara</a></div></div><div id="_co_idm140303002848016"><h3 class="no_margin">Masahiro Abe</h3><p>
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Abe%20M%5BAuthor%5D">Masahiro Abe</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140303046928848_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140303046928848_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140303046928848_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140303046928848_ai" style="display:none"><div class="fm-affl" id="jha2758-aff-0001">
<sup>
1
</sup>
Department of Hematology, 
Endocrinology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</div><div class="fm-affl" id="jha2758-aff-0002">
<sup>
2
</sup>
Department of Oral Function and Anatomy, 
Graduate School of Medicine Dentistry, 
and Pharmaceutical Sciences, 
Okayama University, 
Okayama
Japan
</div><div class="fm-affl" id="jha2758-aff-0003">
<sup>
3
</sup>
Graduate School of Science, 
Osaka Metropolitan University, 
Osaka
Japan
</div><div class="fm-affl" id="jha2758-aff-0004">
<sup>
4
</sup>
Department of Hematology, 
Tokushima University Hospital, 
Tokushima
Japan
</div><div class="fm-affl" id="jha2758-aff-0005">
<sup>
5
</sup>
Department of Community Medicine and Medical Science, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</div><div class="fm-affl" id="jha2758-aff-0006">
<sup>
6
</sup>
Division of Transfusion Medicine and Cell Therapy, 
Tokushima University Hospital, 
Tokushima
Japan
</div><div class="fm-affl" id="jha2758-aff-0007">
<sup>
7
</sup>
Department of Internal Medicine, 
Tokushima Prefecture Naruto Hospital, 
Tokushima
Japan
</div><div class="fm-affl" id="jha2758-aff-0008">
<sup>
8
</sup>
Department of Community Medicine for Respirology, 
Hematology and Metabolism, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</div><div class="fm-affl" id="jha2758-aff-0009">
<sup>
9
</sup>
Department of Bioregulatory Sciences, 
Tokushima University Graduate School of Biomedical Sciences, 
Tokushima
Japan
</div><div class="fm-affl" id="jha2758-aff-0010">
<sup>
10
</sup>
Department of Laboratory Medicine, 
Nagasaki University Hospital, 
Nagasaki
Japan
</div><div class="fm-affl" id="jha2758-aff-0011">
<sup>
11
</sup>
Department of Personalized Cancer Immunotherapy, 
Mie University Graduate School of Medicine, 
Mie
Japan
</div><div><span class="fm-affl">Takeshi Harada, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.u-amihsukot@adarah_ihsekat" class="oemail">pj.ca.u-amihsukot@adarah_ihsekat</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="correspondenceTo"><sup>*</sup>

<strong>Correspondence</strong>
<br />Takeshi Harada, Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, 3&#x02010;18&#x02010;15 Kuramoto&#x02010;cho, Tokushima City, Tokushima, 770&#x02013;8503, Japan.<br />Email: <a href="mailto:dev@null" data-email="pj.ca.u-amihsukot@adarah_ihsekat" class="oemail">pj.ca.u-amihsukot@adarah_ihsekat</a>
<br />
</div></div><div class="fm-article-notes hide half_rhythm" id="idm140303046928848_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 May 31; Revised 2023 Jul 13; Accepted 2023 Jul 14.</div></div><div class="permissions half_rhythm hide" id="idm140303046928848_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 The Authors. <em>eJHaem</em> published by British Society for Haematology and John Wiley &#x00026; Sons Ltd.</div><div class="license half_rhythm">This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by-nc-nd/4.0/</a> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supporting Information</div><div><a href="/pmc/articles/PMC10435715/bin/JHA2-4-667-s001.docx" data-ga-action="click_feat_suppl">JHA2-4-667-s001.docx</a><span style="color:gray"> (1.3M)</span></div><div class="small guid">GUID: FFE806F7-CC4D-46A7-8C51-0C5AE9116A66</div></div></dd></dl><dl data-length="117" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></dd></dl></div><div id="abstract-a.m.b.ab" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.m.b.abtitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Adult T&#x02010;cell leukaemia/lymphoma (ATL) remains incurable. The NF&#x02010;&#x003ba;B and interferon regulatory factor 4 (IRF4) signalling pathways are among the critical survival pathways for the progression of ATL. TGF&#x02010;&#x003b2;&#x02010;activated kinase 1 (TAK1), an I&#x003ba;B kinase&#x02010;activating kinase, triggers the activation of NF&#x02010;&#x003ba;B. The resorcylic acid lactone LL&#x02010;Z1640&#x02010;2 is a potent irreversible inhibitor of TAK1/extracellular signal&#x02010;regulated kinase 2 (ERK2). We herein examined the therapeutic efficacy of LL&#x02010;Z1640&#x02010;2 against ATL. LL&#x02010;Z1640&#x02010;2 effectively suppressed the in vivo growth of ATL cells. It induced in vitro apoptosis and inhibited the nuclear translocation of p65/RelA in ATL cells. The knockdown of <em>IRF4</em> strongly induced ATL cell death while downregulating MYC. LL&#x02010;Z1640&#x02010;2 as well as the NF&#x02010;&#x003ba;B inhibitor BAY11&#x02010;7082 decreased the expression of IRF4 and MYC at the protein and mRNA levels, indicating the suppression of the NF&#x02010;&#x003ba;B&#x02010;IRF4&#x02010;MYC axis. The treatment with LL&#x02010;Z1640&#x02010;2 also mitigated the phosphorylation of p38 MAPK along with the expression of CC chemokine receptor 4. Furthermore, the inhibition of STAT3/5 potentiated the cytotoxic activity of LL&#x02010;Z1640&#x02010;2 against IL&#x02010;2&#x02010;responsive ATL cells in the presence of IL&#x02010;2. Therefore, LL&#x02010;Z1640&#x02010;2 appears to be an effective treatment for ATL. Further studies are needed to develop more potent compounds that retain the active motifs of LL&#x02010;Z1640&#x02010;2.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">ATL, HTLV&#x02010;1, IRF4, NF&#x02010;&#x003ba;B, TAK1</span></div></div><div id="jha2758-abs-0001" lang="en" class="tsec sec"><h2 class="headless nomenu"></h2><!--article-meta--><div><p class="p p-first-last">To develop novel strategies against adult T&#x02010;cell leukemia/lymphoma (ATL), the present study evaluates the impact of targeting both the NF&#x02010;&#x003ba;B&#x02010;IRF4&#x02010;MYC axis and the MAPK signaling pathway in ATL cells by LL&#x02010;Z1640&#x02010;2. Inhibition of STAT3/5 furthermore potentiates the cytotoxic effect of LL&#x02010;Z1640&#x02010;2 in ATL cells even in the presence of IL&#x02010;2.
</p><div class="boxed-text-box whole_rhythm hide-overflow"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303009332704"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g007.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g007.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g007.jpg" /></div></div><p>
</p></div></div><div id="jha2758-sec-0010" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0010title">1. INTRODUCTION</h2><p class="p p-first">Adult T&#x02010;cell leukaemia/lymphoma (ATL) is caused by human T&#x02010;cell leukaemia virus type 1 (HTLV&#x02010;1) infection. The acute and lymphoma types of ATL show aggressive progression with a dismal prognosis [<a href="#jha2758-bib-0001" rid="jha2758-bib-0001" class=" bibr popnode">1</a>, <a href="#jha2758-bib-0002" rid="jha2758-bib-0002" class=" bibr popnode">2</a>, <a href="#jha2758-bib-0003" rid="jha2758-bib-0003" class=" bibr popnode">3</a>]. The NF&#x02010;&#x003ba;B signalling pathway is vital downstream of the T&#x02010;cell receptor (TCR) in malignant progression of HTLV&#x02010;1&#x02010;infected cells [<a href="#jha2758-bib-0004" rid="jha2758-bib-0004" class=" bibr popnode">4</a>]. Genetic alterations have been reported in multiple genes associated with the TCR&#x02010;NF&#x02010;&#x003ba;B signalling pathway in ATL cells, including <em>PLCG1</em>, <em>PRKCB</em> and <em>CARD11</em>, indicating the aberrant activation of NF&#x02010;&#x003ba;B [<a href="#jha2758-bib-0005" rid="jha2758-bib-0005" class=" bibr popnode">5</a>]. Gene alterations enriched in TCR and NF&#x02010;&#x003ba;B signalling pathways are associated with a poor prognosis in patients with ATL [<a href="#jha2758-bib-0005" rid="jha2758-bib-0005" class=" bibr popnode">5</a>, <a href="#jha2758-bib-0006" rid="jha2758-bib-0006" class=" bibr popnode">6</a>]. Therefore, NF&#x02010;&#x003ba;B appears to be an important therapeutic target in ATL cells, and the development of novel agents that effectively preclude the activation of the NF&#x02010;&#x003ba;B signalling pathway is urgently needed to overcome the aggressiveness of ATL cells with drug resistance.</p><p>Transforming growth factor&#x02010;&#x003b2; activated kinase&#x02010;1 (TAK1) is a member of the mitogen&#x02010;activated protein kinase kinase kinase (MAP3K) family that regulates several signalling pathways, including NF&#x02010;&#x003ba;B signal transduction and p38 mitogen&#x02010;activated protein kinase (MAPK) activation [<a href="#jha2758-bib-0007" rid="jha2758-bib-0007" class=" bibr popnode">7</a>]. The aberrant activation of NF&#x02010;&#x003ba;B is generally considered to be essential for inflammation and cancer progression. LL&#x02010;Z1640&#x02010;2, also known as 5Z&#x02010;7&#x02010;oxozeaenol, is a resorcylic acid lactone&#x02010;related compound that was discovered in fungi as an irreversible inhibitor of TAK1/extracellular signal&#x02010;regulated kinase 2 (ERK2) [<a href="#jha2758-bib-0008" rid="jha2758-bib-0008" class=" bibr popnode">8</a>]. Among a series of structurally related resorcylic acid lactones, LL&#x02010;Z1640&#x02010;2 has been identified as the most promising compound based on its inhibitory activity against cell proliferation and the findings of NF&#x02010;&#x003ba;B activation assays [<a href="#jha2758-bib-0009" rid="jha2758-bib-0009" class=" bibr popnode">9</a>]. Furthermore, LL&#x02010;Z1640&#x02010;2 was shown to be the most effective inhibitor of the activation of synovial fibroblasts in rheumatoid arthritis [<a href="#jha2758-bib-0010" rid="jha2758-bib-0010" class=" bibr popnode">10</a>]. We previously reported that LL&#x02010;Z1640&#x02010;2 effectively suppressed inflammation and joint destruction in mice with collagen&#x02010;induced arthritis as a model of rheumatoid arthritis [<a href="#jha2758-bib-0011" rid="jha2758-bib-0011" class=" bibr popnode">11</a>]. Moreover, the therapeutic efficacy of TAK1 inhibition has been examined in preclinical models of various cancers, including mantle cell lymphoma [<a href="#jha2758-bib-0012" rid="jha2758-bib-0012" class=" bibr popnode">12</a>], breast cancer [<a href="#jha2758-bib-0013" rid="jha2758-bib-0013" class=" bibr popnode">13</a>], and ovarian cancer [<a href="#jha2758-bib-0014" rid="jha2758-bib-0014" class=" bibr popnode">14</a>]. We demonstrated the therapeutic impact of LL&#x02010;Z1640&#x02010;2 on tumour progression and bone destruction in animal models of the bone&#x02010;residing tumour multiple myeloma (MM), as well as osteoporotic bone loss in ovariectomised mice [<a href="#jha2758-bib-0015" rid="jha2758-bib-0015" class=" bibr popnode">15</a>].</p><p class="p p-last">Therefore, the potent and irreversible inhibition of TAK1 by LL&#x02010;Z1640&#x02010;2 may be beneficial for suppressing the NF&#x02010;&#x003ba;B and other survival signalling pathways in ATL cells. In the present study, we examined the therapeutic efficacy of LL&#x02010;Z1640&#x02010;2 for ATL. LL&#x02010;Z1640&#x02010;2 effectively suppressed ATL growth in vivo, and induced in vitro apoptosis and inhibited the nuclear translocation of p65/RelA in ATL cells. LL&#x02010;Z1640&#x02010;2 and the inhibition of NF&#x02010;&#x003ba;B reduced the expression of IRF4 and MYC at the protein and mRNA levels. Therefore, LL&#x02010;Z1640&#x02010;2 appears to suppress the NF&#x02010;&#x003ba;B&#x02010;IRF4&#x02010;MYC axis in ATL cells. Furthermore, the inhibition of STAT3/5 potentiated the cytotoxic activity of LL&#x02010;Z1640&#x02010;2 against interleukin&#x02010;2 (IL&#x02010;2)&#x02010;responsive ATL cells in the presence of IL&#x02010;2. Based on these results, LL&#x02010;Z1640&#x02010;2 inhibits critical signalling pathways for ATL cell survival and function and, thus, is an effective treatment for ATL. Further studies are needed to develop potent compounds based on LL&#x02010;Z1640&#x02010;2 as a lead compound to inhibit multiple kinases relevant to the drug resistance of ATL cells.</p></div><div id="jha2758-sec-0020" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0020title">2. MATERIALS AND METHODS</h2><p class="p p-first">For more information regarding this section, see <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">Supporting Information</a>.</p><div id="jha2758-sec-0030" class="sec"><h3 id="jha2758-sec-0030title">2.1. Cells and culture</h3><p class="p p-first-last">The human ATL cell line TL&#x02010;Om1 and the human HTLV&#x02010;1&#x02010;infected cell lines MT&#x02010;2 and Hut102 were kindly provided by Dr. Fujiwara (Mie University). TL&#x02010;Om1 cells expressing <em>luciferase</em> (TL&#x02010;Om1&#x02010;Luc) were generated by retrovirally transducing the MSCV&#x02010;Luc vector into TL&#x02010;Om1 cells. The human ATL cell lines Su9T01, KOB, KK1, LMY1 and ST1 were kindly provided as follows: Su9T01 by Dr. Yoshimitsu (Kagoshima University) and KOB, KK1, LMY1 and ST1 by Dr. Hasegawa (Nagasaki University). The 293T cell line was purchased from the American Type Culture Collection (Manassas). Peripheral blood mononuclear cells (PBMCs) were prepared from blood drawn from healthy volunteers or patients with ATL by Ficoll&#x02010;Paque PLUS (GE Healthcare Bio&#x02010;Sciences AB) density gradient centrifugation. Primary ATL samples were then isolated from PBMCs using the CD4 MicroBeads separation system (Miltenyi Biotec). All procedures involving human specimens were performed with written informed consent according to the Declaration of Helsinki using a protocol approved by the Institutional Review Board (3582 in Tokushima University Hospital).</p></div><div id="jha2758-sec-0040" class="sec"><h3 id="jha2758-sec-0040title">2.2. Transduction</h3><p class="p p-first-last">Lentiviral shRNA&#x02010;containing media were produced according to our previous methods [<a href="#jha2758-bib-0016" rid="jha2758-bib-0016" class=" bibr popnode">16</a>, <a href="#jha2758-bib-0017" rid="jha2758-bib-0017" class=" bibr popnode">17</a>]. Briefly, pLKO&#x02010;based plasmids were transfected into 293T cells in combination with pCMV&#x02010;dvpr and VSV&#x02010;G for lentiviral packaging using TransIT&#x02010;LT1 Transfection Reagent (Mirus Bio). Virus&#x02010;containing media were then harvested. Cells were transfected with lentivirus&#x02010;containing media in the presence of 8&#x000a0;mg/mL polybrene. After an incubation for 3&#x02013;5&#x000a0;h in six&#x02010;well plates, cells were washed with PBS and then cultured with fresh growth media. Cells were selected with 1&#x000a0;&#x003bc;g/mL puromycin for 48&#x000a0;h for further experiments.</p></div><div id="jha2758-sec-0050" class="sec sec-last"><h3 id="jha2758-sec-0050title">2.3. Statistical analysis</h3><p class="p p-first-last">Statistical analyses were conducted using GraphPad Prism (GraphPad Software, version 7). Data distributions were analysed using the <em>&#x003a7;</em>
<sup>2</sup> test. Statistical differences were assessed with the Student's <em>t</em>&#x02010;test for two normally distributed groups and an ordinary one&#x02010;way or two&#x02010;way analysis of variance (ANOVA) with Tukey's test, Sidak's test or Dunnett's test for multiple normally distributed groups. Differences in survival were evaluated by the log&#x02010;rank test. <em>p</em>&#x02010;Values less than 0.05 were considered to be significant.</p></div></div><div id="jha2758-sec-0060" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0060title">3. RESULTS</h2><div id="jha2758-sec-0070" class="sec sec-first"><h3 id="jha2758-sec-0070title">3.1. LL&#x02010;Z1640&#x02010;2 suppresses ATL cell growth and survival</h3><p class="p p-first">Publicly available data showed that <em>MAP3K7</em>, a gene of TAK1, is upregulated in ATL cells (Figure <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">S1A</a>). The NF&#x02010;&#x003ba;B signalling pathway is essential for the survival and proliferation of ATL cells. As TAK1, an I&#x003ba;B kinase&#x02010;activating kinase, triggers the subsequent activation of the NF&#x02010;&#x003ba;B signalling pathway, we initially examined the cytotoxic effects of TAK1 inhibitors on ATL cells. LL&#x02010;Z1640&#x02010;2 is a unique irreversible inhibitor of TAK1 and ERK2 [<a href="#jha2758-bib-0009" rid="jha2758-bib-0009" class=" bibr popnode">9</a>]. LL&#x02010;Z1640&#x02010;2 dose&#x02010;dependently induced cell death with apoptosis in all ATL cell lines (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0001" rid-ob="ob-jha2758-fig-0001" co-legend-rid="lgnd_jha2758-fig-0001"><span>1A</span></a>) and primary ATL cells (Figure <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">S1B</a>). The treatment with LL&#x02010;Z1640&#x02010;2 induced apoptotic cell death, as shown by the results of the annexin V&#x02010;PI assay (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0001" rid-ob="ob-jha2758-fig-0001" co-legend-rid="lgnd_jha2758-fig-0001"><span>1B</span></a> and Figure <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">S1C</a>). However, the reversible TAK1&#x02010;specific inhibitor takinib at the same range of concentrations as LL&#x02010;Z1640&#x02010;2 only weakly induced cell death in the ATL cell lines (Figure <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">S1D</a>). We previously reported the therapeutic efficacy and safety of LL&#x02010;Z1640&#x02010;2 using mouse models of MM with the intra&#x02010;tibial inoculation of MM cells, ovariectomised mice as an osteoporosis model, and mice with collagen&#x02010;induced arthritis as a rheumatoid arthritis model [<a href="#jha2758-bib-0011" rid="jha2758-bib-0011" class=" bibr popnode">11</a>, <a href="#jha2758-bib-0015" rid="jha2758-bib-0015" class=" bibr popnode">15</a>]. Following these experimental procedures, we intraperitoneally injected LL&#x02010;Z1640&#x02010;2 in mouse xenograft models bearing TL&#x02010;Om1 cells. Tumour growth was gradual for the first 2&#x000a0;weeks, and became accelerated thereafter in control mice (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0001" rid-ob="ob-jha2758-fig-0001" co-legend-rid="lgnd_jha2758-fig-0001"><span>1C</span></a>, upper). However, the treatment with LL&#x02010;Z1640&#x02010;2 suppressed tumour growth (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0001" rid-ob="ob-jha2758-fig-0001" co-legend-rid="lgnd_jha2758-fig-0001"><span>1C,D</span></a>). The distribution of bodyweights was similar between the treatment and control groups at each time point (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0001" rid-ob="ob-jha2758-fig-0001" co-legend-rid="lgnd_jha2758-fig-0001"><span>1C</span></a>, lower). These results demonstrate the therapeutic efficacy and safety of LL&#x02010;Z1640&#x02010;2 as a treatment for ATL.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jha2758-fig-0001" co-legend-rid="lgnd_jha2758-fig-0001"><a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/" target="figure" rid-figpopup="jha2758-fig-0001" rid-ob="ob-jha2758-fig-0001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303007101520"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g006.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g006.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g006.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140303007101520"><a target="object" rel="noopener" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jha2758-fig-0001"><div><a class="figpopup" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/" target="figure" rid-figpopup="jha2758-fig-0001" rid-ob="ob-jha2758-fig-0001">FIGURE 1</a></div><!--caption a7--><div class="caption"><p>LL&#x02010;Z1640&#x02010;2 suppresses ATL cell growth and survival in vitro and in vivo. (A) ATL cell lines were cultured in triplicate in the presence of LL&#x02010;Z1640&#x02010;2 at the indicated concentrations for 24 and 48&#x000a0;h. Cell viability was assessed by a CCK&#x02010;8 assay. Data are expressed as a change from the control without LL&#x02010;Z1640&#x02010;2 (means&#x000a0;&#x000b1;&#x000a0;SD). (B) The indicated ATL cell lines were treated with LL&#x02010;Z1640&#x02010;2 at the indicated concentrations for 24&#x000a0;h. Apoptosis was detected using the annexin V&#x02010;propidium iodide (PI) assay. The percentage distributions of annexin V&#x02010;positive apoptotic cells were analysed (means&#x000a0;&#x000b1;&#x000a0;SD). ***<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.001. TL&#x02010;Om1&#x02010;Luc cells were subcutaneously inoculated in NOD/SCID mice. After the development of measurable tumours (&#x0003e;50&#x000a0;mm<sup>3</sup>), mice were treated with LL&#x02010;Z1640&#x02010;2 at 20&#x000a0;mg/kg (<em>n</em>&#x000a0;=&#x000a0;8, blue line) or a vehicle control (<em>n</em>&#x000a0;=&#x000a0;8, black line) 3&#x000a0;days a week for 3&#x000a0;weeks. (C) Tumour growth was monitored with callipers, and mouse bodyweight was measured every 3&#x000a0;days (means&#x000a0;&#x000b1;&#x000a0;SD). **<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.01, ***<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.001. (D) Tumour sizes were also assessed on Day 24 via in vivo bioluminescence measurements using the IVIS Imaging System. Regarding luciferase detection imaging, 100&#x000a0;&#x003bc;L of 15&#x000a0;mg/mL D&#x02010;luciferin in PBS was injected intraperitoneally before taking images. Representative IVIS images on Days 0 and 24 are shown.</p></div></div></div></div><div id="jha2758-sec-0080" class="sec"><h3 id="jha2758-sec-0080title">3.2. LL&#x02010;Z1640&#x02010;2 abrogates the activation of NF&#x02010;&#x003ba;B to induce ATL cell death</h3><p class="p p-first">We investigated the mechanisms underlying the therapeutic effects of LL&#x02010;Z1640&#x02010;2. The NF&#x02010;&#x003ba;B signalling pathway is among the critical survival pathways for the progression and drug resistance of ATL [<a href="#jha2758-bib-0018" rid="jha2758-bib-0018" class=" bibr popnode">18</a>]. In line with the conventional role of TAK1 in NF&#x02010;&#x003ba;B activation, we examined the involvement of NF&#x02010;&#x003ba;B activation in ATL cell death by LL&#x02010;Z1640&#x02010;2. The knockdown of the <em>RELA</em> gene strongly induced apoptosis in ATL cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0002" rid-ob="ob-jha2758-fig-0002" co-legend-rid=""><span>2A</span></a>). BAY11&#x02010;7082 is an I&#x003ba;B&#x003b1; inhibitor that suppresses the activation of NF&#x02010;&#x003ba;B (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0002" rid-ob="ob-jha2758-fig-0002" co-legend-rid=""><span>2B</span></a>). The treatment with BAY11&#x02010;7082 reduced the nuclear localisation of p65 in ATL cells. LL&#x02010;Z1640&#x02010;2 also reduced the nuclear localisation of p65, indicating the suppression of NF&#x02010;&#x003ba;B activity (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0002" rid-ob="ob-jha2758-fig-0002" co-legend-rid=""><span>2C</span></a>). To further confirm the effects of LL&#x02010;Z1640&#x02010;2, we examined the effects of LL&#x02010;Z1640&#x02010;2 on ligand&#x02010;induced NF&#x02010;&#x003ba;B activation. The addition of TNF&#x02010;&#x003b1; induced the translocalisation of p65 from the cytoplasm to nuclei; however, LL&#x02010;Z1640&#x02010;2 markedly reduced the nuclear localisation of p65 in ATL cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0002" rid-ob="ob-jha2758-fig-0002" co-legend-rid=""><span>2D</span></a>). Takinib only slightly affected the nuclear localisation of p65 under these experimental conditions. These results demonstrated that LL&#x02010;Z1640&#x02010;2 effectively suppressed NF&#x02010;&#x003ba;B activity in ATL cells. We also showed that LL&#x02010;Z1640&#x02010;2 suppressed the expression of <em>RELA</em> at the mRNA level (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0002" rid-ob="ob-jha2758-fig-0002" co-legend-rid=""><span>2E</span></a>), indicating the suppression of NF&#x02010;&#x003ba;B activity by LL&#x02010;Z1640&#x02010;2 through the kinase inhibition of TAK1 as an IKK kinase and a reduction in the expression of p65.</p><!--fig-group mode=article f0--><div class="fig-group iconblock whole_rhythm" id="jha2758-fig-0002"><div class="icnblk_cntnt" id=""><div><a class="figpopup" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0002/" target="figure" rid-figpopup="jha2758-fig-0002" rid-ob="ob-">FIGURE 2</a></div><!--caption a7--><div class="caption"><p>LL&#x02010;Z1640&#x02010;2 abrogates NF&#x02010;&#x003ba;B activation to induce ATL cell death. (A) ST1 and TL&#x02010;Om1 cells were transduced with human <em>RELA</em> or <em>Luc</em> shRNA. After puromycin selection, the percentage distributions of annexin V&#x02010;positive apoptotic cells were analysed using an annexin V&#x02010;PI assay (means&#x000a0;&#x000b1;&#x000a0;SD). ***<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.001. Extracted cell lysates were subjected to immunoblotting to detect the p65 protein. &#x003b2;&#x02010;Actin served as a loading control. (B) Hut102 cells were treated with BAY11&#x02010;7082 at 10&#x000a0;&#x003bc;M for 5&#x000a0;h. The p65 protein levels were analysed in cytoplasmic and nuclear extracts by immunoblotting. (C) TL&#x02010;Om1 and Hut102 cells were treated with LL&#x02010;Z1640&#x02010;2 at the indicated concentrations for 5&#x000a0;h. The p65 protein levels were analysed in cytoplasmic and nuclear extracts by immunoblotting. p84 and GAPDH served as loading controls for the nuclear and cytoplasmic extracts, respectively. (D) Su9T01 cells were cultured in RPMI 1640 with 1% FBS for 12&#x000a0;h, and LL&#x02010;Z1640&#x02010;2 or takinib at 10&#x000a0;&#x003bc;M was then added as indicated. Cells were incubated for a further 5&#x000a0;h. TNF&#x02010;&#x003b1; at 10&#x000a0;ng/mL was added as indicated for the last 30&#x000a0;min of the incubation period. Cells were fixed and stained with the anti&#x02010;p65 antibody (red), and their nuclei were stained with DAPI (blue). p65 localisation was observed using a fluorescence microscope. Scale bars represent 20&#x000a0;&#x003bc;m. Original magnification &#x000d7;40. (E) TL&#x02010;Om1 and Su9T01 cells were treated with 10&#x000a0;&#x003bc;M LL&#x02010;Z1640&#x02010;2 for 8&#x000a0;h. Total RNA was isolated and <em>RELA</em> mRNA expression was measured using qPCR. <em>PPIE</em> served as an internal control. Data represent the means&#x000a0;&#x000b1;&#x000a0;SD (<em>n</em>&#x000a0;=&#x000a0;3). ***<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.001. (F) TL&#x02010;Om1 and Hut102 cells were transduced with human <em>RELA</em> or <em>Luc</em> shRNA. After puromycin selection, cell lysates were extracted. p65, TAK1 and MYC protein levels were analysed by immunoblotting. (G) TL&#x02010;Om1 and Hut102 cells were treated for 24&#x000a0;h with BAY11&#x02010;7082 at the indicated concentrations. (F and G) Cell lysates were subjected to immunoblotting to analyse TAK1 and MYC protein levels. &#x003b2;&#x02010;Actin served as a loading control.</p></div><!--fig mode="anchored" f6--><div class="fig iconblock anchored whole_rhythm" id="d96e865"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303007080048"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g005.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g005.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g005.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140303007080048"><a target="object" rel="noopener" href="/pmc/articles/PMC10435715/figure/d96e865/?report=objectonly">Open in a separate window</a></div></div><!--fig mode="anchored" f6--><div class="fig iconblock anchored whole_rhythm" id="d96e867"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303007077872"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g009.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g009.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g009.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140303007077872"><a target="object" rel="noopener" href="/pmc/articles/PMC10435715/figure/d96e867/?report=objectonly">Open in a separate window</a></div></div></div></div><p class="p p-last">We previously reported that the activation of NF&#x02010;&#x003ba;B transcriptionally upregulated TAK1 expression in MM cells, thereby forming an auto&#x02010;amplification loop between TAK1 activation and its expression levels [<a href="#jha2758-bib-0015" rid="jha2758-bib-0015" class=" bibr popnode">15</a>]. Similarly, the knockdown of the <em>RELA</em> gene or a treatment with BAY11&#x02010;7082 reduced TAK1 and MYC protein levels (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0002" rid-ob="ob-jha2758-fig-0002" co-legend-rid=""><span>2F,G</span></a>). ATL cells are also suggested to have the auto&#x02010;amplification of TAK1 activation and its expression.</p></div><div id="jha2758-sec-0090" class="sec"><h3 id="jha2758-sec-0090title">3.3. IRF4 is overexpressed as a vital survival factor in ATL cells</h3><p class="p p-first">Gene expression profiling for primary ATL samples previously demonstrated that the oncogenic transcription factor <em>IRF4</em> was highly expressed in ATL cells [<a href="#jha2758-bib-0005" rid="jha2758-bib-0005" class=" bibr popnode">5</a>, <a href="#jha2758-bib-0019" rid="jha2758-bib-0019" class=" bibr popnode">19</a>]. IRF4 was constitutively overexpressed in all ATL cell lines and primary ATL cells examined in the present study (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0003" rid-ob="ob-jha2758-fig-0003" co-legend-rid="lgnd_jha2758-fig-0003"><span>3A</span></a>). MYC was also overexpressed in these ATL cells at various levels, but was not expressed by normal peripheral blood mononuclear cells. The knockdown of <em>IRF4</em> markedly induced apoptosis while downregulating the expression of MYC in ATL cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0003" rid-ob="ob-jha2758-fig-0003" co-legend-rid="lgnd_jha2758-fig-0003"><span>3B</span></a>). The knockdown of <em>MYC</em> did not affect the expression of IRF4 or p65 in ATL cells, suggesting the overexpression of MYC downstream of IRF4 and NF&#x02010;&#x003ba;B (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0003" rid-ob="ob-jha2758-fig-0003" co-legend-rid="lgnd_jha2758-fig-0003"><span>3C</span></a>). There results demonstrate that IRF4 is overexpressed as a vital survival factor in ATL cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jha2758-fig-0003" co-legend-rid="lgnd_jha2758-fig-0003"><a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0003/" target="figure" rid-figpopup="jha2758-fig-0003" rid-ob="ob-jha2758-fig-0003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303004890144"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g008.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g008.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g008.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140303004890144"><a target="object" rel="noopener" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jha2758-fig-0003"><div><a class="figpopup" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0003/" target="figure" rid-figpopup="jha2758-fig-0003" rid-ob="ob-jha2758-fig-0003">FIGURE 3</a></div><!--caption a7--><div class="caption"><p>IRF4 is overexpressed as a vital survival factor in ATL cells. (A) Whole&#x02010;cell lysates, which were extracted from the ATL cell lines, indicated peripheral blood mononuclear cells (PBMCs) from healthy donors, and primary CD4&#x02010;positive cells derived from patients with ATL were subjected to immunoblotting using the indicated antibodies. &#x003b2;&#x02010;Actin served as a loading control. (B) ST1 and TL&#x02010;Om1 cells were transduced with human <em>IRF4</em> or <em>Luc</em> shRNA. After puromycin selection, the percentage distributions of annexin V&#x02010;positive apoptotic cells were analysed using the annexin V&#x02010;PI assay (means&#x000a0;&#x000b1;&#x000a0;SD). ***<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.001. The extracted cell lysates were subjected to immunoblotting to analyse IRF4 and MYC protein levels. &#x003b2;&#x02010;Actin served as a loading control. (C) The indicated ATL cell lines were transduced with human <em>MYC</em> or <em>Luc</em> shRNA. After puromycin selection, extracted cell lysates were subjected to immunoblotting to analyse MYC, IRF4 and p65 protein levels. &#x003b2;&#x02010;Actin served as a loading control.</p></div></div></div></div><div id="jha2758-sec-0100" class="sec"><h3 id="jha2758-sec-0100title">3.4. LL&#x02010;Z1640&#x02010;2 suppresses the NF&#x02010;&#x003ba;B&#x02010;IRF4 axis in ATL cells</h3><p class="p p-first">NF&#x02010;&#x003ba;B has been shown to enhance IRF4 gene expression [<a href="#jha2758-bib-0020" rid="jha2758-bib-0020" class=" bibr popnode">20</a>, <a href="#jha2758-bib-0021" rid="jha2758-bib-0021" class=" bibr popnode">21</a>], and the NF&#x02010;&#x003ba;B&#x02010;IRF4 axis has also been identified as a pivotal signalling pathway for the survival and proliferation of ATL cells [<a href="#jha2758-bib-0019" rid="jha2758-bib-0019" class=" bibr popnode">19</a>]. The IRF4 and NF&#x02010;&#x003ba;B binding was found to be enriched in super&#x02010;enhancers in ATL cells and formed a feed&#x02010;forward loop to coordinate the regulation of critical oncogenes, including <em>MYC</em> [<a href="#jha2758-bib-0019" rid="jha2758-bib-0019" class=" bibr popnode">19</a>]. Consistent with these findings, the knockdown of <em>RELA</em> reduced both IRF4 and MYC in ATL cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0004" rid-ob="ob-jha2758-fig-0004" co-legend-rid="lgnd_jha2758-fig-0004"><span>4A</span></a>). As suggested by the suppression of NF&#x02010;&#x003ba;B activity (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0002" rid-ob="ob-jha2758-fig-0002" co-legend-rid=""><span>2</span></a>), LL&#x02010;Z1640&#x02010;2 reduced the expression of IRF4 and MYC in ATL cells at the protein and mRNA levels (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0004" rid-ob="ob-jha2758-fig-0004" co-legend-rid="lgnd_jha2758-fig-0004"><span>4B,C</span></a>), indicating the transcriptional regulation of <em>IRF4</em> and <em>MYC</em> gene expression downstream of NF&#x02010;&#x003ba;B signalling in ATL cells in a manner that is inhibited by LL&#x02010;Z1640&#x02010;2.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jha2758-fig-0004" co-legend-rid="lgnd_jha2758-fig-0004"><a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0004/" target="figure" rid-figpopup="jha2758-fig-0004" rid-ob="ob-jha2758-fig-0004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303004870864"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g004.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g004.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g004.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140303004870864"><a target="object" rel="noopener" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jha2758-fig-0004"><div><a class="figpopup" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0004/" target="figure" rid-figpopup="jha2758-fig-0004" rid-ob="ob-jha2758-fig-0004">FIGURE 4</a></div><!--caption a7--><div class="caption"><p>LL&#x02010;Z1640&#x02010;2 suppresses the NF&#x02010;&#x003ba;B&#x02010;IRF4 axis in ATL cells. (A) ST1 and TL&#x02010;Om1 cells were transduced with human <em>RELA</em> or <em>Luc</em> shRNA. After puromycin selection, the extracted cell lysates were subjected to immunoblotting to analyse p65, IRF4 and MYC protein levels. &#x003b2;&#x02010;Actin served as a loading control. (B) The indicated ATL cell lines were cultured with or without LL&#x02010;Z1640&#x02010;2 at 10&#x000a0;&#x003bc;M for 24&#x000a0;h. The extracted cell lysates were subjected to immunoblotting to analyse IRF4 and MYC protein levels. &#x003b2;&#x02010;Actin served as a loading control. (C) Su9T01 and TL&#x02010;Om1 cells were treated with 10&#x000a0;&#x003bc;M LL&#x02010;Z1640&#x02010;2 for 8&#x000a0;h. Total RNA was isolated, and <em>IRF4</em> and <em>MYC</em> mRNA expression was assessed using qPCR. <em>PPIE</em> served as an internal control. Data represent the means&#x000a0;&#x000b1;&#x000a0;SD (<em>n</em>&#x000a0;=&#x000a0;3). **<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.01, ***<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.001.</p></div></div></div></div><div id="jha2758-sec-0110" class="sec"><h3 id="jha2758-sec-0110title">3.5. LL&#x02010;Z1640&#x02010;2 also suppresses signalling pathways other than the NF&#x02010;&#x003ba;B&#x02010;IRF4 axis</h3><p class="p p-first">Although the primary target of LL&#x02010;Z1640&#x02010;2 is TAK1, LL&#x02010;Z1640&#x02010;2 has been shown to exert off&#x02010;target effects, including inhibition of MEK1/2 and MKK3/6 [<a href="#jha2758-bib-0010" rid="jha2758-bib-0010" class=" bibr popnode">10</a>]. The inhibition of MKK3/6&#x02010;p38 MAPK signalling together with TAK1 by LL&#x02010;Z1640&#x02010;2 has been shown to contribute to the anti&#x02010;inflammatory effects of LL&#x02010;Z1640&#x02010;2 in rheumatoid arthritis [<a href="#jha2758-bib-0011" rid="jha2758-bib-0011" class=" bibr popnode">11</a>]. Therefore, we examined the effects of LL&#x02010;Z1640&#x02010;2 on p38 MAPK&#x02010;mediated signalling. The treatment with LL&#x02010;Z1640&#x02010;2 reduced the phosphorylation of p38 MAPK in ATL cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0005" rid-ob="ob-jha2758-fig-0005" co-legend-rid="lgnd_jha2758-fig-0005"><span>5A</span></a>). ATL cells are characterised by the high expression of CC chemokine receptor 4 (CCR4) on their surface. The upregulation of CCR4 in ATL cells was previously shown to be dependent on p38 MAPK [<a href="#jha2758-bib-0022" rid="jha2758-bib-0022" class=" bibr popnode">22</a>]. The treatment with LL&#x02010;Z1640&#x02010;2 reduced the surface levels of CCR4 on ATL cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0005" rid-ob="ob-jha2758-fig-0005" co-legend-rid="lgnd_jha2758-fig-0005"><span>5B</span></a>). Migratory activity toward CCL22 was reduced in the LL&#x02010;Z1640&#x02010;2&#x02010;treated KOB and TL&#x02010;Om1 cells (Figure <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">S2</a>). These results suggest that LL&#x02010;Z1640&#x02010;2 inhibits the clinical manifestation and sequelae mediated by p38 MAPK in ATL cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jha2758-fig-0005" co-legend-rid="lgnd_jha2758-fig-0005"><a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0005/" target="figure" rid-figpopup="jha2758-fig-0005" rid-ob="ob-jha2758-fig-0005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303004859552"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g002.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g002.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g002.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140303004859552"><a target="object" rel="noopener" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jha2758-fig-0005"><div><a class="figpopup" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0005/" target="figure" rid-figpopup="jha2758-fig-0005" rid-ob="ob-jha2758-fig-0005">FIGURE 5</a></div><!--caption a7--><div class="caption"><p>LL&#x02010;Z1640&#x02010;2 suppresses signalling pathways other than the NF&#x02010;&#x003ba;B&#x02010;IRF4 axis. (A) The ATL cell lines indicated were treated with LL&#x02010;Z1640&#x02010;2 at the indicated concentration for 24&#x000a0;h. Whole&#x02010;cell lysates were then extracted from treated cells and subjected to immunoblotting using the indicated antibodies. &#x003b2;&#x02010;Actin served as a loading control. (B) The indicated ATL cell lines were cultured in the presence or absence of LL&#x02010;Z1640&#x02010;2 at the indicated condition for 24&#x000a0;h. The cell surface expression of CCR4 was analysed by flow cytometry. Grey areas indicate background staining with the isotype control IgG.</p></div></div></div></div><div id="jha2758-sec-0120" class="sec sec-last"><h3 id="jha2758-sec-0120title">3.6. LL&#x02010;Z1640&#x02010;2 and the STAT3/5 inhibitor SH&#x02010;4&#x02010;54 synergistically induce cytotoxic activity against ATL cells in the presence of IL&#x02010;2</h3><p class="p p-first">IL&#x02010;2 plays a role in the survival and growth of IL&#x02010;2&#x02010;responsive ATL cells and HTLV&#x02010;1&#x02010;infected T cells. Among STAT family members, STAT3 and STAT5 are implicated in oncogenesis [<a href="#jha2758-bib-0023" rid="jha2758-bib-0023" class=" bibr popnode">23</a>], and <em>STAT3</em> mutations frequently occur in ATL cells [<a href="#jha2758-bib-0005" rid="jha2758-bib-0005" class=" bibr popnode">5</a>, <a href="#jha2758-bib-0006" rid="jha2758-bib-0006" class=" bibr popnode">6</a>]. Nevertheless, exogenous IL&#x02010;2 has been shown to stimulate ATL cell growth and proliferation by activating JAK&#x02010;STAT3/5 signalling [<a href="#jha2758-bib-0024" rid="jha2758-bib-0024" class=" bibr popnode">24</a>, <a href="#jha2758-bib-0025" rid="jha2758-bib-0025" class=" bibr popnode">25</a>]. Therefore, we examined the cytotoxic effects of LL&#x02010;Z1640&#x02010;2 on ATL cells in combination with the STAT3/5 inhibitor SH&#x02010;4&#x02010;54. The addition of IL&#x02010;2 blunted the cytotoxic activity of LL&#x02010;Z1640&#x02010;2 for IL&#x02010;2&#x02010;responsive TL&#x02010;Om1 and Su9T01 cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0006" rid-ob="ob-jha2758-fig-0006" co-legend-rid=""><span>6A</span></a>). The phosphorylation of STAT5 was induced in ATL cells in the presence of IL&#x02010;2 (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0006" rid-ob="ob-jha2758-fig-0006" co-legend-rid=""><span>6B</span></a>). STAT3 was constitutively phosphorylated in Su9T01 and Hut102 cells, but only slightly in TL&#x02010;Om1 cells, and the phosphorylation of STAT3 was upregulated by a stimulation with IL&#x02010;2 (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0006" rid-ob="ob-jha2758-fig-0006" co-legend-rid=""><span>6B</span></a>). The STAT3/5 inhibitor SH&#x02010;4&#x02010;54 abolished the inducible and constitutive phosphorylation of both STAT3 and STAT5 in ATL cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0006" rid-ob="ob-jha2758-fig-0006" co-legend-rid=""><span>6C,D</span></a>). However, LL&#x02010;Z1640&#x02010;2 was not able to inhibit the phosphorylation of STAT5 in TL&#x02010;Om1 cells by IL&#x02010;2 (Figure <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">S3</a>). We then examined the cytotoxic activity of LL&#x02010;Z1640&#x02010;2 in combination with SH&#x02010;4&#x02010;54 against ATL cells in the presence or absence of IL&#x02010;2. The addition of IL&#x02010;2 blunted the cytotoxic effects of LL&#x02010;Z1640&#x02010;2 in IL&#x02010;2&#x02010;responsive TL&#x02010;Om1 cells (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0006" rid-ob="ob-jha2758-fig-0006" co-legend-rid=""><span>6E</span></a>). However, SH&#x02010;4&#x02010;54 at 10&#x000a0;&#x003bc;M sensitised TL&#x02010;Om1 cells to LL&#x02010;Z1640&#x02010;2, and LL&#x02010;Z1640&#x02010;2 and SH&#x02010;4&#x02010;54 cooperatively induced cell death in the presence of IL&#x02010;2. The combination of LL&#x02010;Z and SH4&#x02010;54 exhibited synergistic cytotoxicity against TL&#x02010;Om1 cells in the presence of IL&#x02010;2 (Bliss synergy score of 10.743) (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0006" rid-ob="ob-jha2758-fig-0006" co-legend-rid=""><span>6E</span></a>). The combination of LL&#x02010;Z1640&#x02010;2 and SH&#x02010;4&#x02010;54 more potently induced cell death in IL&#x02010;2&#x02010;dependent ST1 cells in the presence of IL&#x02010;2 (Bliss synergy score of 36.106) (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0006" rid-ob="ob-jha2758-fig-0006" co-legend-rid=""><span>6F</span></a>). The present results suggest that the inhibition of STAT3/5 potentiates the cytotoxic activity of LL&#x02010;Z1640&#x02010;2 against ATL cells in the presence of IL&#x02010;2.</p><!--fig-group mode=article f0--><div class="fig-group iconblock whole_rhythm" id="jha2758-fig-0006"><div class="icnblk_cntnt" id=""><div><a class="figpopup" href="/pmc/articles/PMC10435715/figure/jha2758-fig-0006/" target="figure" rid-figpopup="jha2758-fig-0006" rid-ob="ob-">FIGURE 6</a></div><!--caption a7--><div class="caption"><p>STAT5 inhibition induces synergistic cytotoxic effects of LL&#x02010;Z1640&#x02010;2 in ATL cells in the presence of IL&#x02010;2. (A) TL&#x02010;Om1 and Su9T01 cells were treated with LL&#x02010;Z1640&#x02010;2 at the indicated concentrations in the presence or absence of IL&#x02010;2 (100 U/mL) for 24 and 48&#x000a0;h. Cell viability was assessed by the CCK&#x02010;8 assay. Results are expressed as percentage changes from the controls without LL&#x02010;Z1640&#x02010;2 in the absence of IL&#x02010;2 (<em>n</em>&#x000a0;=&#x000a0;3, means&#x000a0;&#x000b1;&#x000a0;SD). *<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.05, **<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.01, ***<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.001, ns: not significant. (B) Su9T01, Hut102 and TL&#x02010;Om1 cells were cultured in the presence or absence of IL&#x02010;2 (100&#x000a0;U/mL) for 6&#x000a0;h. Whole&#x02010;cell lysates were subjected to immunoblotting using the indicated antibodies. &#x003b2;&#x02010;Actin served as a loading control. (C and D) TL&#x02010;Om1 and Su9T01 cells were treated with or without 10&#x000a0;&#x003bc;M SH&#x02010;4&#x02010;54 for 3&#x000a0;h, cultured in the presence or absence of IL&#x02010;2 (100&#x000a0;U/mL) for 1&#x000a0;h, and the lysates extracted were subjected to immunoblotting using the indicated antibodies. &#x003b2;&#x02010;Actin served as a loading control. (E) TL&#x02010;Om1 cells were treated in triplicate with LL&#x02010;Z1640&#x02010;2 at the indicated concentrations with or without SH4&#x02010;54 at the indicated concentrations in the presence or absence of IL&#x02010;2 (100&#x000a0;U/mL) for 48&#x000a0;h. (F) ST1 cells were treated in triplicate with LL&#x02010;Z1640&#x02010;2 at the indicated concentrations with or without SH4&#x02010;54 at the indicated concentrations in the presence of IL&#x02010;2 (100&#x000a0;U/mL) for 48&#x000a0;h. Cell viability was assessed by a CCK&#x02010;8 assay. The results were expressed as percentage changes from the controls without treatment (means&#x000a0;&#x000b1;&#x000a0;SD). The cells were cultured in the presence of LL&#x02010;Z1640&#x02010;2 and/or SH4&#x02010;54 at the indicated concentrations, and potential synergy was evaluated. Bliss synergy scores were calculated by SynergyFinder 3.0 (<a href="https://synergyfinder.fimm.fi" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://synergyfinder.fimm.fi</a>), and interactive heatmaps are shown.</p></div><!--fig mode="anchored" f6--><div class="fig iconblock anchored whole_rhythm" id="d96e1099"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303001370368"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g001.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g001.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140303001370368"><a target="object" rel="noopener" href="/pmc/articles/PMC10435715/figure/d96e1099/?report=objectonly">Open in a separate window</a></div></div><!--fig mode="anchored" f6--><div class="fig iconblock anchored whole_rhythm" id="d96e1101"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140303001367872"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g003.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JHA2-4-667-g003.jpg" src="/pmc/articles/PMC10435715/bin/JHA2-4-667-g003.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140303001367872"><a target="object" rel="noopener" href="/pmc/articles/PMC10435715/figure/d96e1101/?report=objectonly">Open in a separate window</a></div></div></div></div></div></div><div id="jha2758-sec-0130" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0130title">4. DISCUSSION</h2><p class="p p-first">The present results show that LL&#x02010;Z1640&#x02010;2 inhibited NF&#x02010;&#x003ba;B and IRF4 signalling and induced cell death in ATL cells. TAK1 expression was transcriptionally upregulated in ATL cells by the activation of NF&#x02010;&#x003ba;B downstream of TAK1, suggesting a feed&#x02010;forward amplification mechanism of TAK1 by itself. One of the distinct characteristics of LL&#x02010;Z1640&#x02010;2 is its irreversibility, which differs from other TAK1 inhibitors, including takinib. Irreversible binding to TAK1 induces the potent and prolonged suppression of kinase activity [<a href="#jha2758-bib-0009" rid="jha2758-bib-0009" class=" bibr popnode">9</a>], which may contribute to the stronger cytotoxic activity of LL&#x02010;Z1640&#x02010;2 against ATL cells than that of takinib. LL&#x02010;Z1640&#x02010;2 may also inhibit MKK3/6 and MEK1/2, which is regarded as an off&#x02010;target effect of LL&#x02010;Z1640&#x02010;2 [<a href="#jha2758-bib-0010" rid="jha2758-bib-0010" class=" bibr popnode">10</a>]. LL&#x02010;Z1640&#x02010;2 suppressed not only the activation of NF&#x02010;&#x003ba;B, but also other mediators responsible for activation of growth and survival pathways in ATL cells, including p38 MAPK&#x02010;mediated pathway (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0005" rid-ob="ob-jha2758-fig-0005" co-legend-rid="lgnd_jha2758-fig-0005"><span>5</span></a>). Multiple activated mutations in different factors may result in refractoriness to treatment with molecular targeted agents against ATL. Nonetheless, LL&#x02010;Z1640&#x02010;2 was effective against ATL cells. However, CCR4 expression and phosphorylated p38 levels recovered in ATL cells in a time&#x02010;dependent manner after the removal of LL&#x02010;Z1640&#x02010;2 (Figure <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">S4</a>). Although LL&#x02010;Z1640&#x02010;2 irreversibly binds the ATP pocket in TAK1, nascent TAK1 over&#x02010;produced in ATL cells can mitigate the suppression of the activity of TAK1 and TAK1&#x02010;dependent p38 MAPK after the removal of LL&#x02010;Z1640&#x02010;2. Repeated exposure to LL&#x02010;Z1640&#x02010;2 is needed to maintain its anti&#x02010;ATL activity as we did in the in vivo models (Figure&#x000a0;<a href="/pmc/articles/PMC10435715/figure/jha2758-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jha2758-fig-0001" rid-ob="ob-jha2758-fig-0001" co-legend-rid="lgnd_jha2758-fig-0001"><span>1C,D</span></a>). In addition, LL&#x02010;Z1640&#x02010;2 suppressed the incorporation of puromycin in ATL cells (Figure <a href="#jha2758-supitem-0001" rid="jha2758-supitem-0001" class=" supplementary-material">S5</a>), which is indicative of the suppression of translation. The suppression of translation may explain the unique activity of LL&#x02010;Z1640&#x02010;2 in terms of potent cytotoxic activity against ATL cells with multiple mutations. However, the mechanisms underlying the anti&#x02010;ATL effects of LL&#x02010;Z1640&#x02010;2 are yet to be elucidated in detail.</p><p>Due to its potent activity, we showed the therapeutic efficacy of LL&#x02010;Z1640&#x02010;2 for MM [<a href="#jha2758-bib-0015" rid="jha2758-bib-0015" class=" bibr popnode">15</a>]. Adhesion between MM cells and bone marrow stromal cells (BMSCs) has been shown to induce the production of IL&#x02010;6 and expression of receptor activator of NF&#x02010;&#x003ba;B ligand (RANKL) in BMSCs. Treatment with LL&#x02010;Z1640&#x02010;2 abolishes MM cell&#x02013;BMSC adhesion, thereby suppressing the production of IL&#x02010;6 and expression of RANKL in BMSCs. LL&#x02010;Z1640&#x02010;2 has also been shown to inhibit RANKL&#x02010;mediated osteoclastogenesis. These results indicate the therapeutic impact of LL&#x02010;Z1640&#x02010;2 targeting the tumour microenvironment. Therefore, LL&#x02010;Z1640&#x02010;2 may also affect cellular signalling pathways in different cell types in the tumour macroenvironment together with ATL cells. In the present study, we found that LL&#x02010;Z1640&#x02010;2 decreased the expression of CCR4 on the surface of ATL cells, which has been suggested to mitigate the activation [<a href="#jha2758-bib-0026" rid="jha2758-bib-0026" class=" bibr popnode">26</a>] and migratory function [<a href="#jha2758-bib-0027" rid="jha2758-bib-0027" class=" bibr popnode">27</a>] of ATL cells in response to microenvironmental stimuli. Regulatory T cells (Tregs), normal counterparts of ATL cells, play an important role in the evasion of cancer from immune surveillance [<a href="#jha2758-bib-0028" rid="jha2758-bib-0028" class=" bibr popnode">28</a>]. LL&#x02010;Z1640&#x02010;2 may suppress the expression of CCR4 on the surface of Tregs, thereby reducing their immunosuppressive function. TAK1 is an essential mediator of TGF&#x02010;&#x003b2; signalling, which is required for the induction of Tregs [<a href="#jha2758-bib-0029" rid="jha2758-bib-0029" class=" bibr popnode">29</a>]. Therefore, the inhibition of TAK1 may suppress the induction of Tregs. The broader functions of TAK1 are yet to be clarified in other immune and non&#x02010;immune cell types in the tumour microenvironment.</p><p class="p p-last">The present results demonstrated that the combination of LL&#x02010;Z1640&#x02010;2 and STAT3/5 inhibitors exhibited cooperative therapeutic activities against ATL cells, which warrants further study on a precise cross&#x02010;talk between the TAK1 and STAT3/5&#x02010;mediated signalling pathways in IL&#x02010;2&#x02010;responsive ATL cells. Based on the safety profiles of LL&#x02010;Z1640&#x02010;2 in the in vivo models, the combination of LL&#x02010;Z1640&#x02010;2 with other anti&#x02010;ATL drugs, including STAT3/5 inhibitors, may be envisioned. The potent clinical efficacy and safety profiles of LL&#x02010;Z1640&#x02010;2 in the in vivo models of ATL and MM prompted us to synthesise new compounds based on the structure&#x02013;activity relationship of LL&#x02010;Z1640&#x02010;2. To further enhance their targeting efficiency, we are examining a liposome&#x02010;mediated drug delivery system with LL&#x02010;Z1640&#x02010;2 and its derived compounds.</p></div><div id="jha2758-sec-0140" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0140title">AUTHOR CONTRIBUTIONS</h2><p class="p p-first-last">Masahiro Oura and Takeshi Harada designed the study. Masahiro Oura, Takeshi Harada, Asuka Oda, Jumpei Teramachi, Ryohei Sumitani and Yusuke Inoue performed experiments and analysed data. Atushi Nakayama synthesised LL&#x02010;Z1640&#x02010;2. Masahiro Oura, Takeshi Harada, Ryohei Sumitani, Kimiko Sogabe, Tomoko Maruhashi, Mamiko Takahashi, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Masafumi Nakamura, Yusaku Maeda, Tomoyo Hara and Hiroki Yamagami provided clinical samples. Hiroo Hasegawa and Hiroshi Fujiwara provided ATL cell lines and reviewed data. Kiyoe Kurahashi and Itsuro Endo reviewed data. Masahiro Abe supervised the study design and experiments. Masahiro Oura, Takeshi Harada and Masahiro Abe wrote the manuscript. Masahiro Oura, Takeshi Harada and Masahiro Abe reviewed and edited the manuscript.</p></div><div id="jha2758-sec-0160" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0160title">CONFLICT OF INTEREST STATEMENT</h2><p class="p p-first-last">Takeshi Harada received research funding from Nippon Shinyaku. Masahiro Abe received research funding from Chugai Pharmaceutical, Sanofi K.K., Pfizer Seiyaku K.K., Kyowa Hakko Kirin, MSD K.K., GSK, Nippon Shinyaku, Astellas Pharma, Takeda Pharmaceutical, Teijin Pharma and Ono Pharmaceutical, and honoraria from Janssen. The remaining authors declare no conflicts of interest.</p></div><div id="jha2758-sec-0170" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0170title">CLINICAL TRIAL REGISTRATION</h2><p class="p p-first-last">The authors have confirmed clinical trial registration is not needed for this submission.</p></div><div id="jha2758-sec-0200" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0200title">ETHICS APPROVAL STATEMENT</h2><p class="p p-first-last">All animal studies were performed under a protocol approved by the Animal Ethics Committee of Tokushima University (T2019&#x02010;80).</p></div><div id="jha2758-sec-0210" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0210title">PATIENT CONSENT STATEMENT</h2><p class="p p-first-last">All procedures involving human specimens were performed with written informed consent according to the Declaration of Helsinki using a protocol approved by the Institutional Review Board (3582 in Tokushima University Hospital).</p></div><div id="sec-a.n.j" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.n.jtitle">Supporting information</h2><!--/article/body/sec/--><div class="sec suppmat" id="jha2758-supitem-0001"><p>Supporting Information</p><div class="sup-box half_rhythm" id="media-a.n.j.b.b"><a href="/pmc/articles/PMC10435715/bin/JHA2-4-667-s001.docx" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(1.3M, docx)</sup></div></div></div><div id="jha2758-sec-0150" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0150title">ACKNOWLEDGEMENTS</h2><div class="sec"><p>We thank Dr. Yoshimitsu for providing the ATL cell lines. This work was supported in part by JSPS KAKENHI (Grant Numbers: JP20K06939, JP20K17402, JP21H03111, JP22K08455, JP22K19626, JP22H03104, JP23K06051); a research grant from Nippon Shinyaku to Takeshi Harada; and the Research Clusters Program of Tokushima University (2202003, 1803003). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></div></div><div id="notes-a.m.c" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.m.ctitle">Notes</h2><p>
<span class="mixed-citation" id="jha2758-cit-0030">
Oura M, Harada T, Oda A, Teramachi J, Nakayama A, Sumitani R, et&#x000a0;al. <span class="ref-title">Therapeutic efficacy of the resorcylic acid lactone LL&#x02010;Z1640&#x02010;2 for adult T&#x02010;cell leukaemia/lymphoma</span>. <span class="ref-journal">eJHaem</span>. 2023;<span class="ref-vol">4</span>:667&#x02013;678. 10.1002/jha2.758
 [<a href="//doi.org/10.1002%2Fjha2.758" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=eJHaem&amp;title=Therapeutic+efficacy+of+the+resorcylic+acid+lactone+LL&#x02010;Z1640&#x02010;2+for+adult+T&#x02010;cell+leukaemia/lymphoma&amp;volume=4&amp;publication_year=2023&amp;pages=667-678&amp;doi=10.1002/jha2.758&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span>
</p></div><div id="jha2758-sec-0190" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="jha2758-sec-0190title">DATA AVAILABILITY STATEMENT</h2><!--/article/back/sec/--><p class="p p-first-last">The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></div><div id="jha2758-bibl-0001" class="tsec sec"><h2 class="head no_bottom_margin" id="jha2758-bibl-0001title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0001">1. <span class="mixed-citation" id="jha2758-cit-0001">
Watanabe T. <span class="ref-title">Adult T&#x02010;cell leukemia: molecular basis for clonal expansion and transformation of HTLV&#x02010;1&#x02010;infected T cells</span>. <span class="ref-journal">Blood</span>. 2017;<span class="ref-vol">129</span>(<span class="ref-iss">9</span>):1071&#x02013;81. 10.1182/blood-2016-09-692574
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5374731/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28115366" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2016-09-692574" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Adult+T&#x02010;cell+leukemia:+molecular+basis+for+clonal+expansion+and+transformation+of+HTLV&#x02010;1&#x02010;infected+T+cells&amp;volume=129&amp;issue=9&amp;publication_year=2017&amp;pages=1071-81&amp;pmid=28115366&amp;doi=10.1182/blood-2016-09-692574&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0002">2. <span class="mixed-citation" id="jha2758-cit-0002">
Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et&#x000a0;al. <span class="ref-title">Treatment and survival among 1594 patients with ATL</span>. <span class="ref-journal">Blood</span>. 2015;<span class="ref-vol">126</span>(<span class="ref-iss">24</span>):2570&#x02013;7. 10.1182/blood-2015-03-632489
 [<a href="https://pubmed.ncbi.nlm.nih.gov/26361794" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2015-03-632489" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Treatment+and+survival+among+1594+patients+with+ATL&amp;volume=126&amp;issue=24&amp;publication_year=2015&amp;pages=2570-7&amp;pmid=26361794&amp;doi=10.1182/blood-2015-03-632489&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0003">3. <span class="mixed-citation" id="jha2758-cit-0003">
Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, et&#x000a0;al. <span class="ref-title">Revised Adult T&#x02010;Cell Leukemia&#x02010;Lymphoma International Consensus meeting report</span>. <span class="ref-journal">J Clin Oncol</span>. 2019;<span class="ref-vol">37</span>(<span class="ref-iss">8</span>):677&#x02013;87. 10.1200/jco.18.00501
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6494249/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30657736" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2Fjco.18.00501" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Revised+Adult+T&#x02010;Cell+Leukemia&#x02010;Lymphoma+International+Consensus+meeting+report&amp;volume=37&amp;issue=8&amp;publication_year=2019&amp;pages=677-87&amp;pmid=30657736&amp;doi=10.1200/jco.18.00501&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0004">4. <span class="mixed-citation" id="jha2758-cit-0004">
Harhaj EW, Giam CZ. <span class="ref-title">NF&#x02010;&#x003ba;B signaling mechanisms in HTLV&#x02010;1&#x02010;induced adult T&#x02010;cell leukemia/lymphoma</span>. <span class="ref-journal">FEBS J</span>. 2018;<span class="ref-vol">285</span>(<span class="ref-iss">18</span>):3324&#x02013;36. 10.1111/febs.14492
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6750271/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29722927" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Ffebs.14492" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+J&amp;title=NF&#x02010;&#x003ba;B+signaling+mechanisms+in+HTLV&#x02010;1&#x02010;induced+adult+T&#x02010;cell+leukemia/lymphoma&amp;volume=285&amp;issue=18&amp;publication_year=2018&amp;pages=3324-36&amp;pmid=29722927&amp;doi=10.1111/febs.14492&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0005">5. <span class="mixed-citation" id="jha2758-cit-0005">
Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, et&#x000a0;al. <span class="ref-title">Integrated molecular analysis of adult T cell leukemia/lymphoma</span>. <span class="ref-journal">Nat Genet</span>. 2015;<span class="ref-vol">47</span>(<span class="ref-iss">11</span>):1304&#x02013;15. 10.1038/ng.3415
 [<a href="https://pubmed.ncbi.nlm.nih.gov/26437031" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fng.3415" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Integrated+molecular+analysis+of+adult+T+cell+leukemia/lymphoma&amp;volume=47&amp;issue=11&amp;publication_year=2015&amp;pages=1304-15&amp;pmid=26437031&amp;doi=10.1038/ng.3415&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0006">6. <span class="mixed-citation" id="jha2758-cit-0006">
Kataoka K, Iwanaga M, Yasunaga JI, Nagata Y, Kitanaka A, Kameda T, et&#x000a0;al. <span class="ref-title">Prognostic relevance of integrated genetic profiling in adult T&#x02010;cell leukemia/lymphoma</span>. <span class="ref-journal">Blood</span>. 2018;<span class="ref-vol">131</span>(<span class="ref-iss">2</span>):215&#x02013;25. 10.1182/blood-2017-01-761874
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5757690/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29084771" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2017-01-761874" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Prognostic+relevance+of+integrated+genetic+profiling+in+adult+T&#x02010;cell+leukemia/lymphoma&amp;volume=131&amp;issue=2&amp;publication_year=2018&amp;pages=215-25&amp;pmid=29084771&amp;doi=10.1182/blood-2017-01-761874&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0007">7. <span class="mixed-citation" id="jha2758-cit-0007">
Sakurai H. <span class="ref-title">Targeting of TAK1 in inflammatory disorders and cancer</span>. <span class="ref-journal">Trends Pharmacol Sci</span>. 2012;<span class="ref-vol">33</span>(<span class="ref-iss">10</span>):522&#x02013;30. 10.1016/j.tips.2012.06.007
 [<a href="https://pubmed.ncbi.nlm.nih.gov/22795313" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.tips.2012.06.007" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;title=Targeting+of+TAK1+in+inflammatory+disorders+and+cancer&amp;volume=33&amp;issue=10&amp;publication_year=2012&amp;pages=522-30&amp;pmid=22795313&amp;doi=10.1016/j.tips.2012.06.007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0008">8. <span class="mixed-citation" id="jha2758-cit-0008">
Ninomiya&#x02010;Tsuji J, Kajino T, Ono K, Ohtomo T, Matsumoto M, Shiina M, et&#x000a0;al. <span class="ref-title">A resorcylic acid lactone, 5Z&#x02010;7&#x02010;oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase</span>. <span class="ref-journal">J Biol Chem</span>. 2003;<span class="ref-vol">278</span>(<span class="ref-iss">20</span>):18485&#x02013;90. 10.1074/jbc.M207453200
 [<a href="https://pubmed.ncbi.nlm.nih.gov/12624112" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M207453200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=A+resorcylic+acid+lactone,+5Z&#x02010;7&#x02010;oxozeaenol,+prevents+inflammation+by+inhibiting+the+catalytic+activity+of+TAK1+MAPK+kinase+kinase&amp;volume=278&amp;issue=20&amp;publication_year=2003&amp;pages=18485-90&amp;pmid=12624112&amp;doi=10.1074/jbc.M207453200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0009">9. <span class="mixed-citation" id="jha2758-cit-0009">
Wu J, Powell F, Larsen NA, Lai Z, Byth KF, Read J, et&#x000a0;al. <span class="ref-title">Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)&#x02010;7&#x02010;oxozeaenol</span>. <span class="ref-journal">ACS Chem Biol</span>. 2013;<span class="ref-vol">8</span>(<span class="ref-iss">3</span>):643&#x02013;50. 10.1021/cb3005897
 [<a href="https://pubmed.ncbi.nlm.nih.gov/23272696" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1021%2Fcb3005897" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Chem+Biol&amp;title=Mechanism+and+in+vitro+pharmacology+of+TAK1+inhibition+by+(5Z)&#x02010;7&#x02010;oxozeaenol&amp;volume=8&amp;issue=3&amp;publication_year=2013&amp;pages=643-50&amp;pmid=23272696&amp;doi=10.1021/cb3005897&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0010">10. <span class="mixed-citation" id="jha2758-cit-0010">
Jones DS, Jenney AP, Swantek JL, Burke JM, Lauffenburger DA, Sorger PK. <span class="ref-title">Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation</span>. <span class="ref-journal">Nat Chem Biol</span>. 2017;<span class="ref-vol">13</span>(<span class="ref-iss">1</span>):38&#x02013;45. 10.1038/nchembio.2211
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5372219/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27820799" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnchembio.2211" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Chem+Biol&amp;title=Profiling+drugs+for+rheumatoid+arthritis+that+inhibit+synovial+fibroblast+activation&amp;volume=13&amp;issue=1&amp;publication_year=2017&amp;pages=38-45&amp;pmid=27820799&amp;doi=10.1038/nchembio.2211&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0011">11. <span class="mixed-citation" id="jha2758-cit-0011">
Tenshin H, Teramachi J, Ashtar M, Hiasa M, Inoue Y, Oda A, et&#x000a0;al. <span class="ref-title">TGF&#x02010;&#x003b2;&#x02010;activated kinase&#x02010;1 inhibitor LL&#x02010;Z1640&#x02010;2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF&#x02010;&#x003b1; and RANKL expression</span>. <span class="ref-journal">Clin Transl Immunol</span>. 2022;<span class="ref-vol">11</span>(<span class="ref-iss">1</span>):e1371. 10.1002/cti2.1371
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8770968/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35079379" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fcti2.1371" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Transl+Immunol&amp;title=TGF&#x02010;&#x003b2;&#x02010;activated+kinase&#x02010;1+inhibitor+LL&#x02010;Z1640&#x02010;2+reduces+joint+inflammation+and+bone+destruction+in+mouse+models+of+rheumatoid+arthritis+by+inhibiting+NLRP3+inflammasome,+TACE,+TNF&#x02010;&#x003b1;+and+RANKL+expression&amp;volume=11&amp;issue=1&amp;publication_year=2022&amp;pages=e1371&amp;doi=10.1002/cti2.1371&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0012">12. <span class="mixed-citation" id="jha2758-cit-0012">
Buglio D, Palakurthi S, Byth K, Vega F, Toader D, Saeh J, et&#x000a0;al. <span class="ref-title">Essential role of TAK1 in regulating mantle cell lymphoma survival</span>. <span class="ref-journal">Blood</span>. 2012;<span class="ref-vol">120</span>(<span class="ref-iss">2</span>):347&#x02013;55. 10.1182/blood-2011-07-369397
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3460632/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22649101" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2011-07-369397" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Essential+role+of+TAK1+in+regulating+mantle+cell+lymphoma+survival&amp;volume=120&amp;issue=2&amp;publication_year=2012&amp;pages=347-55&amp;pmid=22649101&amp;doi=10.1182/blood-2011-07-369397&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0013">13. <span class="mixed-citation" id="jha2758-cit-0013">
Safina A, Ren MQ, Vandette E, Bakin AV. <span class="ref-title">TAK1 is required for TGF&#x02010;beta 1&#x02010;mediated regulation of matrix metalloproteinase&#x02010;9 and metastasis</span>. <span class="ref-journal">Oncogene</span>. 2008;<span class="ref-vol">27</span>(<span class="ref-iss">9</span>):1198&#x02013;207. 10.1038/sj.onc.1210768
 [<a href="https://pubmed.ncbi.nlm.nih.gov/17828308" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1210768" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=TAK1+is+required+for+TGF&#x02010;beta+1&#x02010;mediated+regulation+of+matrix+metalloproteinase&#x02010;9+and+metastasis&amp;volume=27&amp;issue=9&amp;publication_year=2008&amp;pages=1198-207&amp;pmid=17828308&amp;doi=10.1038/sj.onc.1210768&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0014">14. <span class="mixed-citation" id="jha2758-cit-0014">
Cai PC, Shi L, Liu VW, Tang HW, Liu IJ, Leung TH, et&#x000a0;al. <span class="ref-title">Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF&#x02010;&#x003ba;B signaling</span>. <span class="ref-journal">Oncotarget</span>. 2014;<span class="ref-vol">5</span>(<span class="ref-iss">17</span>):7549&#x02013;62. 10.18632/oncotarget.2273
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4202143/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25277189" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.2273" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Elevated+TAK1+augments+tumor+growth+and+metastatic+capacities+of+ovarian+cancer+cells+through+activation+of+NF&#x02010;&#x003ba;B+signaling&amp;volume=5&amp;issue=17&amp;publication_year=2014&amp;pages=7549-62&amp;pmid=25277189&amp;doi=10.18632/oncotarget.2273&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0015">15. <span class="mixed-citation" id="jha2758-cit-0015">
Teramachi J, Tenshin H, Hiasa M, Oda A, Bat&#x02010;Erdene A, Harada T, et&#x000a0;al. <span class="ref-title">TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma</span>. <span class="ref-journal">Haematologica</span>. 2021;<span class="ref-vol">106</span>(<span class="ref-iss">5</span>):1401&#x02013;13. 10.3324/haematol.2019.234476
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8094086/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32273474" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3324%2Fhaematol.2019.234476" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=TAK1+is+a+pivotal+therapeutic+target+for+tumor+progression+and+bone+destruction+in+myeloma&amp;volume=106&amp;issue=5&amp;publication_year=2021&amp;pages=1401-13&amp;pmid=32273474&amp;doi=10.3324/haematol.2019.234476&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0016">16. <span class="mixed-citation" id="jha2758-cit-0016">
Harada T, Ohguchi H, Grondin Y, Kikuchi S, Sagawa M, Tai YT, et&#x000a0;al. <span class="ref-title">HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications</span>. <span class="ref-journal">Leukemia</span>. 2017;<span class="ref-vol">31</span>(<span class="ref-iss">12</span>):2670&#x02013;7. 10.1038/leu.2017.144
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5681897/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28490812" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fleu.2017.144" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=HDAC3+regulates+DNMT1+expression+in+multiple+myeloma:+therapeutic+implications&amp;volume=31&amp;issue=12&amp;publication_year=2017&amp;pages=2670-7&amp;pmid=28490812&amp;doi=10.1038/leu.2017.144&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0017">17. <span class="mixed-citation" id="jha2758-cit-0017">
Harada T, Ohguchi H, Oda A, Nakao M, Teramachi J, Hiasa M, et&#x000a0;al. <span class="ref-title">Novel antimyeloma therapeutic option with inhibition of the HDAC1&#x02010;IRF4 axis and PIM kinase</span>. <span class="ref-journal">Blood Adv</span>. 2023;<span class="ref-vol">7</span>(<span class="ref-iss">6</span>):1019&#x02013;32. 10.1182/bloodadvances.2022007155
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10036510/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36129197" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fbloodadvances.2022007155" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood+Adv&amp;title=Novel+antimyeloma+therapeutic+option+with+inhibition+of+the+HDAC1&#x02010;IRF4+axis+and+PIM+kinase&amp;volume=7&amp;issue=6&amp;publication_year=2023&amp;doi=10.1182/bloodadvances.2022007155&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0018">18. <span class="mixed-citation" id="jha2758-cit-0018">
Yamagishi M, Watanabe T. <span class="ref-title">Molecular hallmarks of adult T cell leukemia</span>. <span class="ref-journal">Front Microbiol</span>. 2012;<span class="ref-vol">3</span>:334. 10.3389/fmicb.2012.00334
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3444139/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23060864" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffmicb.2012.00334" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Microbiol&amp;title=Molecular+hallmarks+of+adult+T+cell+leukemia&amp;volume=3&amp;publication_year=2012&amp;pages=334&amp;pmid=23060864&amp;doi=10.3389/fmicb.2012.00334&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0019">19. <span class="mixed-citation" id="jha2758-cit-0019">
Wong RWJ, Tan TK, Amanda S, Ngoc PCT, Leong WZ, Tan SH, et&#x000a0;al. <span class="ref-title">Feed&#x02010;forward regulatory loop driven by IRF4 and NF&#x02010;&#x003ba;B in adult T&#x02010;cell leukemia/lymphoma</span>. <span class="ref-journal">Blood</span>. 2020;<span class="ref-vol">135</span>(<span class="ref-iss">12</span>):934&#x02013;47. 10.1182/blood.2019002639
 [<a href="https://pubmed.ncbi.nlm.nih.gov/31972002" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood.2019002639" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Feed&#x02010;forward+regulatory+loop+driven+by+IRF4+and+NF&#x02010;&#x003ba;B+in+adult+T&#x02010;cell+leukemia/lymphoma&amp;volume=135&amp;issue=12&amp;publication_year=2020&amp;pages=934-47&amp;pmid=31972002&amp;doi=10.1182/blood.2019002639&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0020">20. <span class="mixed-citation" id="jha2758-cit-0020">
Boddicker RL, Kip NS, Xing X, Zeng Y, Yang ZZ, Lee JH, et&#x000a0;al. <span class="ref-title">The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF&#x02010;&#x003ba;B positive feedback loop in peripheral T&#x02010;cell lymphoma</span>. <span class="ref-journal">Blood</span>. 2015;<span class="ref-vol">125</span>(<span class="ref-iss">20</span>):3118&#x02013;27. 10.1182/blood-2014-05-578575
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4432006/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25833963" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2014-05-578575" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=The+oncogenic+transcription+factor+IRF4+is+regulated+by+a+novel+CD30/NF&#x02010;&#x003ba;B+positive+feedback+loop+in+peripheral+T&#x02010;cell+lymphoma&amp;volume=125&amp;issue=20&amp;publication_year=2015&amp;pages=3118-27&amp;pmid=25833963&amp;doi=10.1182/blood-2014-05-578575&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0021">21. <span class="mixed-citation" id="jha2758-cit-0021">
Grumont RJ, Gerondakis S. <span class="ref-title">Rel induces interferon regulatory factor 4 (IRF&#x02010;4) expression in lymphocytes: modulation of interferon&#x02010;regulated gene expression by rel/nuclear factor kappaB</span>. <span class="ref-journal">J Exp Med</span>. 2000;<span class="ref-vol">191</span>(<span class="ref-iss">8</span>):1281&#x02013;92. 10.1084/jem.191.8.1281
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2193138/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10770796" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1084%2Fjem.191.8.1281" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Rel+induces+interferon+regulatory+factor+4+(IRF&#x02010;4)+expression+in+lymphocytes:+modulation+of+interferon&#x02010;regulated+gene+expression+by+rel/nuclear+factor+kappaB&amp;volume=191&amp;issue=8&amp;publication_year=2000&amp;pages=1281-92&amp;pmid=10770796&amp;doi=10.1084/jem.191.8.1281&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0022">22. <span class="mixed-citation" id="jha2758-cit-0022">
Nakayama T, Hieshima K, Arao T, Jin Z, Nagakubo D, Shirakawa AK, et&#x000a0;al. <span class="ref-title">Aberrant expression of Fra&#x02010;2 promotes CCR4 expression and cell proliferation in adult T&#x02010;cell leukemia</span>. <span class="ref-journal">Oncogene</span>. 2008;<span class="ref-vol">27</span>(<span class="ref-iss">23</span>):3221&#x02013;32. 10.1038/sj.onc.1210984
 [<a href="https://pubmed.ncbi.nlm.nih.gov/18071306" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1210984" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Aberrant+expression+of+Fra&#x02010;2+promotes+CCR4+expression+and+cell+proliferation+in+adult+T&#x02010;cell+leukemia&amp;volume=27&amp;issue=23&amp;publication_year=2008&amp;pages=3221-32&amp;pmid=18071306&amp;doi=10.1038/sj.onc.1210984&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0023">23. <span class="mixed-citation" id="jha2758-cit-0023">
Wingelhofer B, Neubauer HA, Valent P, Han X, Constantinescu SN, Gunning PT, et&#x000a0;al. <span class="ref-title">Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer</span>. <span class="ref-journal">Leukemia</span>. 2018;<span class="ref-vol">32</span>(<span class="ref-iss">8</span>):1713&#x02013;26. 10.1038/s41375-018-0117-x
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6087715/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29728695" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41375-018-0117-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Implications+of+STAT3+and+STAT5+signaling+on+gene+regulation+and+chromatin+remodeling+in+hematopoietic+cancer&amp;volume=32&amp;issue=8&amp;publication_year=2018&amp;pages=1713-26&amp;pmid=29728695&amp;doi=10.1038/s41375-018-0117-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0024">24. <span class="mixed-citation" id="jha2758-cit-0024">
Chen J, Petrus M, Bryant BR, Nguyen VP, Goldman CK, Bamford R, et&#x000a0;al. <span class="ref-title">Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T&#x02010;cell leukemia</span>. <span class="ref-journal">Blood</span>. 2010;<span class="ref-vol">116</span>(<span class="ref-iss">26</span>):5948&#x02013;56. 10.1182/blood-2010-04-277418
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3031384/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20858854" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2010-04-277418" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Autocrine/paracrine+cytokine+stimulation+of+leukemic+cell+proliferation+in+smoldering+and+chronic+adult+T&#x02010;cell+leukemia&amp;volume=116&amp;issue=26&amp;publication_year=2010&amp;pages=5948-56&amp;pmid=20858854&amp;doi=10.1182/blood-2010-04-277418&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0025">25. <span class="mixed-citation" id="jha2758-cit-0025">
Zhang M, Mathews Griner LA, Ju W, Duveau DY, Guha R, Petrus MN, et&#x000a0;al. <span class="ref-title">Selective targeting of JAK/STAT signaling is potentiated by Bcl&#x02010;xL blockade in IL&#x02010;2&#x02010;dependent adult T&#x02010;cell leukemia</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>. 2015;<span class="ref-vol">112</span>(<span class="ref-iss">40</span>):12480&#x02013;5. 10.1073/pnas.1516208112
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4603455/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26396258" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.1516208112" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Selective+targeting+of+JAK/STAT+signaling+is+potentiated+by+Bcl&#x02010;xL+blockade+in+IL&#x02010;2&#x02010;dependent+adult+T&#x02010;cell+leukemia&amp;volume=112&amp;issue=40&amp;publication_year=2015&amp;pages=12480-5&amp;pmid=26396258&amp;doi=10.1073/pnas.1516208112&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0026">26. <span class="mixed-citation" id="jha2758-cit-0026">
Nakagawa M, Schmitz R, Xiao W, Goldman CK, Xu W, Yang Y, et&#x000a0;al. <span class="ref-title">Gain&#x02010;of&#x02010;function CCR4 mutations in adult T cell leukemia/lymphoma</span>. <span class="ref-journal">J Exp Med</span>. 2014;<span class="ref-vol">211</span>(<span class="ref-iss">13</span>):2497&#x02013;505. 10.1084/jem.20140987
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4267233/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25488980" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1084%2Fjem.20140987" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Gain&#x02010;of&#x02010;function+CCR4+mutations+in+adult+T+cell+leukemia/lymphoma&amp;volume=211&amp;issue=13&amp;publication_year=2014&amp;pages=2497-505&amp;pmid=25488980&amp;doi=10.1084/jem.20140987&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0027">27. <span class="mixed-citation" id="jha2758-cit-0027">
Yoshie O, Fujisawa R, Nakayama T, Harasawa H, Tago H, Izawa D, et&#x000a0;al. <span class="ref-title">Frequent expression of CCR4 in adult T&#x02010;cell leukemia and human T&#x02010;cell leukemia virus type 1&#x02010;transformed T cells</span>. <span class="ref-journal">Blood</span>. 2002;<span class="ref-vol">99</span>(<span class="ref-iss">5</span>):1505&#x02013;11. 10.1182/blood.v99.5.1505
 [<a href="https://pubmed.ncbi.nlm.nih.gov/11861261" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood.v99.5.1505" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Frequent+expression+of+CCR4+in+adult+T&#x02010;cell+leukemia+and+human+T&#x02010;cell+leukemia+virus+type+1&#x02010;transformed+T+cells&amp;volume=99&amp;issue=5&amp;publication_year=2002&amp;pages=1505-11&amp;pmid=11861261&amp;doi=10.1182/blood.v99.5.1505&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0028">28. <span class="mixed-citation" id="jha2758-cit-0028">
Ohue Y, Nishikawa H. <span class="ref-title">Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?</span>
<span class="ref-journal">Cancer Sci</span>. 2019;<span class="ref-vol">110</span>(<span class="ref-iss">7</span>):2080&#x02013;9. 10.1111/cas.14069
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6609813/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31102428" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fcas.14069" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci&amp;title=Regulatory+T+(Treg)+cells+in+cancer:+can+Treg+cells+be+a+new+therapeutic+target?&amp;volume=110&amp;issue=7&amp;publication_year=2019&amp;pages=2080-9&amp;pmid=31102428&amp;doi=10.1111/cas.14069&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jha2758-bib-0029">29. <span class="mixed-citation" id="jha2758-cit-0029">
Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. <span class="ref-title">The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function</span>. <span class="ref-journal">Nat Immunol</span>. 2006;<span class="ref-vol">7</span>(<span class="ref-iss">8</span>):851&#x02013;8. 10.1038/ni1355
 [<a href="https://pubmed.ncbi.nlm.nih.gov/16799562" ref="reftype=pubmed&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fni1355" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&amp;title=The+kinase+TAK1+integrates+antigen+and+cytokine+receptor+signaling+for+T+cell+development,+survival+and+function&amp;volume=7&amp;issue=8&amp;publication_year=2006&amp;pages=851-8&amp;pmid=16799562&amp;doi=10.1038/ni1355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10435715&amp;issue-id=443375&amp;journal-id=4199&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">EJHaem</span> are provided here courtesy of <strong>Wiley</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10435715/pdf/JHA2-4-667.pdf" class="int-view">PDF (2.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10435715/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10435715/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10435715" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10435715%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="Ox0UX80RlFNysx2M2ugJvfu9FAMbg2MRVBMwLl2YA54Iei3xsmM6r66VU0BSBb6K">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10435715%2F&amp;text=Therapeutic%20efficacy%20of%20the%20resorcylic%20acid%20lactone%20LL%02010Z1640%020102%20for%20adult%20T%02010cell%20leukaemia%2Flymphoma%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10435715%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435715/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10435715/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37601887/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10435715/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37601887/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10435715/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10435715/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10435715/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
